Mark Lawler Discusses Lancet Oncology Commission on Precision Oncology
Mark Lawler discusses the Lancet Oncology Commission's findings on genomics and precision oncology in a new podcast. The commission highlights unequal access to cancer genetic testing worldwide and calls for policies to make precision cancer care affordable, especially in India. Experts emphasize the need for a five-year policy agenda to expand precision oncology care and ensure equitable treatment globally.
Oncodaily·13h ago



